NEJM This Week – Audio Summaries
New medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.
NEJM This Week — November 30, 2023
Featuring articles on levothyroxine for unstable brain-dead heart donors, amivantamab in lung cancer with EGFR exon 20 insertions, amikacin to prevent ventilator-associated pneumonia, and tarlatamab in small-cell lung cancer, a new series on wearable digital health technology with a review article on digital technology for diabetes; a case report of a man with sickle cell disease and right hip pain; and Perspectives on coverage for emerging technologies, on methadone clinic engagement and cancer care, and on learning from the bomb. Supplement to the New England Journal of Medicine, Vol. 389, No. 22.
November 29, 2023
NEJM This Week — November 23, 2023
Featuring articles on osimertinib and chemotherapy in EGFR-mutated non–small-cell lung cancer, transcatheter aortic-valve replacement in low-risk patients at five years, erdafitinib or chemotherapy in urothelial carcinoma, and liver transplantation for Mahvash disease; a review article on postmenopausal osteoporosis; a case report of a man with diabetes and kidney cysts; and Perspectives on opening the door to international medical graduates, on community-engaged research, and on woman, life, freedom. Supplement to the New England Journal of Medicine, Vol. 389, No. 21.
November 22, 2023
NEJM This Week — November 16, 2023
Featuring articles on selpercatinib in RET fusion–positive NSCLC, selpercatinib in RET-mutant medullary thyroid cancer, gantenerumab in early Alzheimer’s disease, and stimulated copeptin to diagnose AVP deficiency; a review article on liver transplantation; a case report of a woman with waxing and waning pulmonary nodules; and Perspective articles on Rift Valley fever, on implanting a recalled device, and on biopsies from healthy volunteers in precision medicine. Supplement to the New England Journal of Medicine, Vol. 389, No. 20.
November 15, 2023
NEJM This Week — November 9, 2023
Featuring articles on genetic variation and life span in Iceland, botulinum toxin for head tremor, decolonization in nursing homes to prevent infection, nivolumab plus chemotherapy in urothelial carcinoma, pembrolizumab in pregnancy, and on after affirmative action; a review article on catatonia; a case report of a woman with loss of consciousness and thrombocytopenia; and Perspective articles on how the FDA should evaluate psychedelic medicine, on federal oversight of laboratory-developed tests, and on the corporate divorce between two major Boston medical institutions. Supplement to the New England Journal of Medicine, Vol. 389, No. 19.
November 8, 2023
NEJM This Week — November 2, 2023
Featuring articles on thalidomide for recurrent bleeding due to small-intestinal angiodysplasia, pulsed field ablation for paroxysmal atrial fibrillation, perioperative chemoimmunotherapy in lung cancer, and corin and cardiac phenotypes; a review article on cystic fibrosis; a Clinical Problem-Solving on being encased in peril; and Perspective articles on minimum-staffing rules for U.S. nursing homes, on reforming pharmacy benefit managers, on scaling up point-of-care fentanyl testing, and on familiar shadows. Supplement to the New England Journal of Medicine, Vol. 389, No. 18.
November 1, 2023
NEJM This Week — October 26, 2023
Featuring articles on patisiran for transthyretin cardiac amyloidosis, automated insulin delivery in pregnancy complicated by diabetes, nemolizumab for prurigo nodularis, convalescent plasma for Covid-19–induced ARDS, and debt collection in American medicine; a case report of a man with shortness of breath; and Perspective articles on climate, health, and equity under the Farm Bill; on indigenous health perspectives on the Lāhainā fires, on whether price negotiations delay cancer-drug launches, and on the standard of care. Supplement to the New England Journal of Medicine, Vol. 389, No. 17.
October 25, 2023
NEJM This Week — October 19, 2023
Featuring articles on on enzalutamide and leuprolide in prostate cancer, optical coherence tomography (OCT)–guided versus angiography-guided PCI, vancomycin and cefazolin prophylaxis in arthroplasty, and on OCT and eye care; a review article on the syndrome of inappropriate antidiuresis; a case report of a woman with recurrent hemorrhagic pericardial effusion; and Perspective articles on Yellow Jack’s potential return to the American South; on wedding websites, free speech, and adverse drug effects; and on a chance to modernize health care behind bars. Supplement to the New England Journal of Medicine, Vol. 389, No. 16.
October 18, 2023
NEJM This Week — October 12, 2023
Featuring articles on dexamethasone for TB meningitis in HIV-positive adults, the timing of complete revascularization after myocardial infarction, catheter ablation for advanced heart failure and AFib, ceftobiprole for Staph. aureus bacteremia, and on AlphaFold being recognized through a Lasker Award; a review article on Shiga toxin–producing E. coli and the hemolytic–uremic syndrome; a case report of a man with involuntary movements and unresponsiveness; and Perspective articles on whether pandemics ever end, on the new over-the-counter oral contraceptive pill, and on a reason to retire. Supplement to the New England Journal of Medicine, Vol. 389, No. 15.
October 11, 2023
About NEJM This Week - Audio Summaries
The New England Journal of Medicine (NEJM) Weekly Audio Summary RSS Feed. NEJM is a weekly general medicinal journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.
You may also like
Join our community and never miss
your favorite episodes
Join Our Newsletter
We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.
Network Sponsors and Advertisers
Event and Media Partners
